Literature DB >> 9887449

Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

P J Pauwels1, T Wurch.   

Abstract

Guanine nucleotide-binding protein-coupled receptors may attain an active conformation in the absence of agonist by spontaneous isomerization and thus yield constitutive, agonist-independent, activity. This has mainly been demonstrated for isolated membranes and recombinant wild-type receptors, and mutant receptors. They generally show remarkable increases in the sensitivity of a biological response. The location of activating mutations both within a single receptor and across receptors is widespread, with changes reported in the seven-transmembrane domains, the second and third intracellular loop. For most of these receptors, examples of ligands defined as inverse agonists have been documented. Regulation of these receptors by inverse agonists opposite to that observed by agonists, and the therapeutic potential of inverse agonists is underlined.

Mesh:

Substances:

Year:  1998        PMID: 9887449     DOI: 10.1007/BF02802027

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  138 in total

Review 1.  Reverse intrinsic activity of antagonists on G protein-coupled receptors.

Authors:  W Schütz; M Freissmuth
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

2.  Constitutively active mutants of rhodopsin.

Authors:  P R Robinson; G B Cohen; E A Zhukovsky; D D Oprian
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

3.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation.

Authors:  M A Kjelsberg; S Cotecchia; J Ostrowski; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

Review 4.  Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction.

Authors:  A M Spiegel; A Shenker; L S Weinstein
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

5.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.

Authors:  T Costa; Y Ogino; P J Munson; H O Onaran; D Rodbard
Journal:  Mol Pharmacol       Date:  1992-03       Impact factor: 4.436

6.  Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists.

Authors:  H Ma; R D Green
Journal:  Mol Pharmacol       Date:  1992-11       Impact factor: 4.436

Review 7.  Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.

Authors:  M Deakin; J G Williams
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 8.  Sequence alignment of the G-protein coupled receptor superfamily.

Authors:  W C Probst; L A Snyder; D I Schuster; J Brosius; S C Sealfon
Journal:  DNA Cell Biol       Date:  1992 Jan-Feb       Impact factor: 3.311

9.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure.

Authors:  T Okamoto; I Nishimoto
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

10.  Mutational analysis of third cytoplasmic loop domains in G-protein coupling of the HM1 muscarinic receptor.

Authors:  J R Arden; O Nagata; M S Shockley; M Philip; J Lameh; W Sadée
Journal:  Biochem Biophys Res Commun       Date:  1992-11-16       Impact factor: 3.575

View more
  13 in total

1.  Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.

Authors:  D Ramsay; N Bevan; S Rees; G Milligan
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis.

Authors:  A Chen; Z G Gao; D Barak; B T Liang; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

3.  Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven.

Authors:  Séverine Barroso; Françoise Richard; Delphine Nicolas-Ethève; Patrick Kitabgi; Catherine Labbé-Jullié
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Modeling the human PTC bitter-taste receptor interactions with bitter tastants.

Authors:  Wely B Floriano; Spencer Hall; Nagarajan Vaidehi; Unkyung Kim; Dennis Drayna; William A Goddard
Journal:  J Mol Model       Date:  2006-04-11       Impact factor: 1.810

5.  Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.

Authors:  Gonzalo Romero; Elisabeth Sánchez; Marta Pujol; Pilar Pérez; Xavier Codony; Jörg Holenz; Helmut Buschmann; Petrus J Pauwels
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

6.  Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.

Authors:  P J Pauwels; A Gouble; T Wurch
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

7.  LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system.

Authors:  Ephraim L Tsalik; Timothy Niacaris; Adam S Wenick; Kelvin Pau; Leon Avery; Oliver Hobert
Journal:  Dev Biol       Date:  2003-11-01       Impact factor: 3.582

8.  Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor.

Authors:  Anke Niedernberg; Andree Blaukat; Torsten Schöneberg; Evi Kostenis
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

Review 9.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388

10.  Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening.

Authors:  Karl Brillet; Brigitte L Kieffer; Dominique Massotte
Journal:  BMC Pharmacol       Date:  2003-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.